SCHEMBL7373377

SCHEMBL7373377

O=C1NCCCc2cn[nH]c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 5/20 0.42
DRD2 P14416 3/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
KDR P35968 2/20 0.40
MAPK10 P53779 2/20 0.40
RIPK1 Q13546 2/20 0.40
MAP2K1 Q02750 3/20 0.38
AURKA O14965 2/20 0.38
PLK4 O00444 2/20 0.38
DAPK3 O43293 2/20 0.38
PIM1 P11309 2/20 0.38
PDGFRA P16234 2/20 0.38
LTK P29376 2/20 0.38
MAP2K2 P36507 2/20 0.38
FLT3 P36888 2/20 0.38
MAPK8 P45983 2/20 0.38
MAPK9 P45984 2/20 0.38
CSNK1A1 P48729 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5763909 0.89 PARP10 (0.41) DRD4DRD2HTR2AHTR2CHTR2B
SCHEMBL2198319 0.76
SCHEMBL6792890 0.75 DRD4 (0.50) DRD4DRD2HTR2AHTR2CHTR2B
SCHEMBL3519382 0.72
SCHEMBL20919789 0.70 CDC7 (0.45) KDRPLK4DAPK3CSNK1A1CDK8
SCHEMBL7156772 0.69 MAP2K1 (0.52) MAP2K1CDK5CHEK1PRKD3ALDH1A1
SCHEMBL21248417 0.69 FABP6 (0.41) MAPK10RIPK1GSK3BALDH1A1KDM4E
SCHEMBL15814733 0.67 DRD4 (0.35) DRD4DRD2HTR2AHTR2CHTR2B
SCHEMBL21614784 0.67 DRD4 (0.46) DRD4DRD2HTR2AHTR2CHTR2B
SCHEMBL21614796 0.67 DRD4 (0.50) DRD4DRD2HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140941-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP claimed
WO-2000039131-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-07-06 WO claimed
EP-1140941-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-10-10 EP disclosed
WO-2000039131-A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-07-06 WO disclosed